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ISONIAZID IN THE TREATMENT OF SARCOIDOSIS*
A PRELIMINARY REPORT
EDMOND EDELSON, M.D.
In a recent paper (1) on the usefulness of isoniazid in the treatment of discoid
lupus erythematosus, mention was made of trials then under way with this
medication in sarcoidosis. This report will summarize briefly our findings in the
latter studies.
The following table lists sex, age, area of cutaneous involvement, other sites
of involvement, abnormal Roentgen and laboratory findings, duration of ther-
apy, total dose of isoniazid and the results obtained in the six ambulatory pa-
tients we observed. In all of these, the clinical diagnosis of sarcoidosis was con-
firmed by histopathologic examination. Tuberculin tests (2) were negative in
four instances (Cases 1, 2, 3, 5) and weakly positive in two (Cases 4, 6).
The initial dose of isoniazid given orally was 1 mg./kg. of body weight per
day for one or more weeks and this was gradually increased. Almost all patients
tolerated a daily dose of 3 mg./kg. If on rare occasions a patient complained of
slight gaseous distress and mild headaches, this level was reduced to 2 mg./kg.
On subsidence of these side effects, the dose was again increased to 3 mg./kg.
All patients reported to the clinic at weekly intervals. The following abstracts
from the case histories supplement the data presented in Table I.
Case 1 (R. F.): Biopsy specimens taken from the lip on July 9, 1948 and from the chin on
February 8, 1952 showed the typical sarcoid structure primarily in the corium. There was
no evidence of fibrosis or loss of cellular clarity. The patient had had slight but persistent
itching for the past several years. The pruritus as well as the lesions had been unaffected
by calciferol, arsenicals and foreign protein injections. Isoniazid initiated March 3, 1952
promptly relieved her pruritus. Within one month the lesions decreased in size materially.
However, biopsy specimens taken from the nose on April 14, and from the lip on November
12 showed no change. Mild complaints of malaise and easy fatiguability disappeared two
months after institution of isoniazid. On November 12 isoniazid therapy was discontinued
for three weeks because of surgery for uterine fibroids. The pruritus returned and the lesions
increased to almost the original size. Subsequently, isoniazid therapy was quite irregular.
Strict adherence to isoniazid therapy since February 2, 1953 again produced definite im-
provement.
Case (E. T.): Biopsy specimens from the area of the inferior turbinates on May 16, 1952
and from the skin of the forehead on June 20 showed sarcoid structure as did an earlier
biopsy from a cervical lymph node. Aside from the skin lesion, symptoms consisted of
coughing, nasal blockage, and facial swelling. One week after institution of isoniazid (June
20), the patient reported that her nasal passages felt clearer, that she coughed much less,
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and that her friends had noted diminution of facial swelling. Two months later neck glands
were also definitely smaller and she felt stronger. Headaches, gradually increasing for
three weeks, led to discontinuance of isoniazid on December 15. A skin biopsy at this time
failed to show any change. The headaches subsided, but by December22 the glands became
slightly larger and the nose "stuffed". Therefore, isoniazid was resumed. Within one month
there was some degree of improvement and this has been maintained on continuation of
therapy. The headaches did not recur. The sedimentation rate, corrected for anemia, im-
proved but the serum proteins remained about the same.
Case 3 (E. H.): A large red beefy mass protruded from the left eyeball. Biopsy specimens
from the parotid (3) and cervical glands were typical of sarcoid. There was no change after
three months of therapy with isoniazid, when the patient was lost from observation. At that
time she still complained of some weakness, dizziness, chest pains and headaches, and had
irregular bouts of fever. We did not have the opportunity to re-examine another biopsy
specimen during the short course of therapy.
Case , CM. W.): The only manifestations were a progressive increase in size and number
of lesions during aS to 6 year period. A biopsy taken in April, 1952 showed sarcoid structure
primarily in the corium. Under otherwise uneventful isoniazid therapy, about one quarter
of the lesions decreased in size, but none disappeared. However, no new lesions developed
and none became enlarged. A biopsy taken in February, 1953 from a clinically improved
lesion revealed no change as compared with the original specimen.
Case 5 (.1. M.): During the past 3 to 4 years numerous individual lesions had become
confluent to form multiple plaques on the cheeks, forehead, and sides of the nose. A biopsy
taken in June, 1952 showed tubercles mainly in the corium. Isoniazid therapy was continued
for over six months, by which time most of the plaques had become paler and definitely
flatter. However, another biopsy specimen taken in January, 1953 revealed no change from
the original specimen.
Case 6 (I. F.): A diagnosis of sarcoidosis was first made at the University of Pennsylvania
Hospital in 1949 from a biopsy specimen taken from a left axillary node. The patient's left
eye was enucleated in August, 1950 for iridocyclitis and keratitis (3), which on biopsy was
"compatible with Boeck's sarcoid." Histopathologic examination of a lymph node from
the left elbow area on July 10, 1951 confirmed the previous biopsy findings. One and one-half
months of isoniazid produced no improvement in the skin or bilateral axillary and left
olecranon adenopathy. The patient declined further therapy because of mild headaches
attributed to isoniazid.
COMMENT AND SUMMARY
Six cases of sarcoidosis proven by histopathologic examination were treated
with isoniazid. One of these (I. F.) was lost from observation after only 1
months of therapy with no improvement. Similarly, another patient (E. H.)
derived no benefit from isoniazid administered for a period of three months. The
remaining four cases, in three of which detectable lesions were confined to the
skin, showed definite subjective and objective improvement. However, biopsy
specimens taken at the time of the clinical improvement revealed no change in
the histopathologic picture. None of the fibrotic or cellular changes often seen
in involuting sarcoidosis could be found. The serum protein abnormalities re-
mained unchanged in patient E. T. The sedimentation rates and blood counts
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returned to normal in one case (R. F.) and almost to normal in another case
(E. T.).
In summary, treatment with isoniazid produced definite clinical improvement
in four cases of sarcoidosis. These patients received the medication for 53
months and longer. Two patients treated for shorter periods derived no benefit.
The ultimate results, as well as the modus operandi, remain to be evaluated.
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